Top Markets
#1 ADO Protocol ADO Protocol +194.72%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.67%
#7 Wrapped NXM Wrapped NXM +14.87%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +13.32%
#10 Pons Pons +12.61%
Coin of the day
ADO Protocol ADO Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Rang in Aktien #33752
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Aktienkurs
$0.4523
Zuletzt synchronisiert: 2023-03-03
Marktkapitalisierung
$6.97M
Veränderung (1 Tag)
-19.23%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Lucira Health, Inc. (LHDX)

Kategorie

Healthcare
Aktien-Split-Historie für Lucira Health, Inc. (LHDX)
Die Aktie Lucira Health, Inc. (Symbol: LHDX) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 17, 2026 statt.
Eine LHDX-Aktie, die vor dem Aug 17, 2026 gekauft wurde, entspricht heute 0 LHDX-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 9 x285
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 9 x162
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 7 x127
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2 x4
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 3 x12
US